Noven Pharmaceuticals, Inc.

FL · United States · Reporting entity ID 100000000219

Total reported 2019–2025

$16.2M

#365 of 2,960 reporting companies — 0% of all reported industry payments

$817K in general payments across 1,405 records, plus $15.4M in research funding across 1,014 records.

How it breaks down

General payments $817,213

Research funding $15,432,465

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.